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Abstract
Nitric oxide (NO) and its derivatives inhibit mitochondrial respiration by a variety of means. Nanomolar concentrations of
NO immediately, specifically and reversibly inhibit cytochrome oxidase in competition with oxygen, in isolated cytochrome
oxidase, mitochondria, nerve terminals, cultured cells and tissues. Higher concentrations of NO and its derivatives
(peroxynitrite, nitrogen dioxide or nitrosothiols) can cause irreversible inhibition of the respiratory chain, uncoupling,
permeability transition, and/or cell death. Isolated mitochondria, cultured cells, isolated tissues and animals in vivo display
respiratory inhibition by endogenously produced NO from constitutive isoforms of NO synthase (NOS), which may be
largely mediated by NO inhibition of cytochrome oxidase. Cultured cells expressing the inducible isoform of NOS (iNOS)
can acutely and reversibly inhibit their own cellular respiration and that of co-incubated cells due to NO inhibition of
cytochrome oxidase, but after longer-term incubation result in irreversible inhibition of cellular respiration due to NO or its
derivatives. Thus the NO inhibition of cytochrome oxidase may be involved in the physiological and/or pathological
regulation of respiration rate, and its affinity for oxygen. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
This paper reviews what is known about nitric
oxide (NO) regulation of mitochondrial respiration
via reversible NO inhibition of cytochrome c oxidase.
A number of other reviews of this or related topics
have appeared recently [1^5]. NO has a variety of
e¡ects on mitochondria that need to be distin-
guished: (a) at low concentrations, for short periods,
NO speci¢cally and reversibly inhibits cytochrome
oxidase, but (b) higher levels of NO, more prolonged
exposure to NO, or conversion of NO to one of its
more reactive oxides results in irreversible inhibition
of respiration and other damage to mitochondria.
This review concentrates on the former, reversible
e¡ects of NO, but in order to distinguish these ef-
fects, and to understand the literature historically, I
will ¢rst brie£y outline the biology of NO and the
irreversible e¡ects of NO on respiration.
In eukaryotic cells NO is mainly produced by the
enzyme nitric oxide synthase (NOS), of which there
are three known isoforms: nNOS (neuronal NOS,
type I NOS), iNOS (inducible NOS, type II NOS)
and eNOS (endothelial NOS, type III NOS) [6,7].
NOS uses substrates arginine, NADPH and oxygen,
and produces citrulline, NADP and NO. nNOS and
eNOS are constitutively expressed in endothelium,
platelets, some neurons and at lower levels a variety
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of other cells. nNOS and eNOS are acutely activated
by calcium/calmodulin, alternatively they may be ac-
tivated or inhibited by phosphorylation via various
protein kinases [6]. iNOS is not normally expressed,
but its expression is induced by cytokines (such as
interferon-Q, IL-1L, and TNF-K), endotoxin (LPS),
and/or oxidative stress. Once iNOS is expressed it
is continuously active and is not dependent on ele-
vated calcium, so that it can produce higher levels of
NO and for a much longer period than eNOS or
nNOS. eNOS and nNOS are transiently activated,
and are involved in regulating physiological func-
tions, whereas iNOS is expressed and is continuously
active during in£ammation, where it is involved in
host-defence against pathogens. There is some evi-
dence that mitochondria may also contain NOS
(mtNOS) [8,9], but the nature of this mtNOS and
its relation to other NOS isoforms is still unclear.
NO may also be generated non-enzymatically from
nitrite at low pH in the presence of reductants, but
again it is unclear how signi¢cant this pathway is
[10]. The main sources of NO and their activators
are summarised in Fig. 1.
Once NO is produced it may react with a number
of molecules (Fig. 2). NO reacts rapidly with high
a⁄nity to ferrous iron (Fe2), either free iron, iron
within iron^sulphur centres, or iron within haempro-
teins, particularly those where the haem has a free
ligand position [11]. The major physiological actions
of NO (such as relaxation of smooth muscle, neuro-
transmission, and inhibition of platelet aggregation
and adhesion) are mediated by NO binding to the
ferrous haem iron of soluble guanylate cyclase, caus-
ing a stimulation of cGMP production [12]. The
main route by which NO is broken down in the
body is thought to be the reaction of NO with hae-
moglobin in blood [13]. But NO can also bind to and
inhibit other haemproteins with a free ligand posi-
tion, such as cytochrome oxidase and catalase [11].
NO also reacts directly with oxygen to produce NO2
and N2O3, which are strong oxidants, but this reac-
tion is thought to be relatively slow at physiological
levels of NO [14]. NO reacts at the di¡usion limited
rate with superoxide (O32 ) to produce another strong
oxidant peroxynitrite (ONOO3), and peroxynitrite
has in the past been blamed for much of the cytotox-
icity of NO [14]. NO can also react indirectly with
thiols (e.g. glutathione or protein cysteine residues)
to produce S-nitrosothiols (RSNO) [15]. However,
NO itself does not directly react with thiols, but re-
quires conversion to NO or an NO donor, such as
peroxynitrite, NO2 or N2O3 [15]. Nitrosothiols can
directly transfer the NO group to other thiols, and
may regulate protein functions by this means [15].
2. Irreversible inhibition of respiration by NO and its
derivatives
In the 1980’s it was shown that activated macro-
phages could kill tumour cells, and this NO-depen-
dent activity was associated with a characteristic set
of metabolic changes in both the target tumour cells
and the macrophages, in particular inhibitions of mi-
tochondrial aconitase, complex I and complex II,
and the loss of intracellular iron [16^20]. These
changes were reproduced by incubating the cells an-
aerobically with high levels of NO [17,19], and it was
suggested that the changes were caused by NO dis-
placing iron from the iron^sulphur centres of aconi-
tase, complex I and complex II [17]. High levels of
NO (about 1 mM) can indeed reversibly or irrever-
sibly damage the mitochondrial iron^sulphur centres
Fig. 1. Sources of NO. In mammalian cells NO may be derived
from di¡erent isoforms of NO synthase (nNOS, iNOS or
eNOS), or possibly mitochondrial NOS (mtNOS), and in acid
conditions reductants may reduce nitrite to NO.
Fig. 2. Main reactions of NO. NO may reversible bind to fer-
rous iron within haemproteins, such as guanylate cyclase, hae-
moglobin and cytochrome oxidase. At high concentrations NO
may react with oxygen to produce NO2 and N2O3. NO reacts
at the di¡usion limited rate with superoxide to produce peroxy-
nitrite. NO, after oxidation to NO or peroxynitrite, can react
with thiols to produce nitrosothiols.
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[21,22] but whether this is responsible for the irre-
versible inhibition of cellular respiration by NO is
less clear.
NO can rapidly react with superoxide to produce
peroxynitrite (ONOO3), and peroxynitrite can cause
irreversible inhibition of mitochondrial respiration
and damage to a variety of mitochondrial compo-
nents via oxidising reactions. Peroxynitrite inhibits
or damages mitochondrial complexes I and II, the
ATP synthase, aconitase, creatine kinase, the mito-
chondrial membrane, mitochondrial DNA, superox-
ide dismutase, and induces mitochondrial swelling,
uncoupling, depolarisation, calcium release and per-
meability transition (see [1,23^25]). Peroxynitrite or
high levels of NO (s 1 WM) also irreversibly inhibit
cytochrome oxidase and raise its Km for oxygen [26].
Thus peroxynitrite has been blamed for much of the
pathology and cell death induced by NO; however, it
still remains unclear whether NO-induced cell death
or irreversible inhibition of mitochondrial respiration
is partly mediated by peroxynitrite.
The cause of irreversible respiratory inhibition was
recently re-examined in cultured cells treated with the
NO donor DETA-NONOate (2,2P-(hydroxynitroso-
hydrazino) bis-ethanamine, also known as NOC-18)
for several hours [27,28]. Irreversible inhibition of
respiration occurred after a delay of several hours,
at a time when cellular glutathione levels were de-
pleted, and was mainly due to the inhibition of com-
plex I. Surprisingly both the inhibition of respiration
and of complex I could be completely reversed by
light, dithiothreitol or glutathione methyl ester, sug-
gesting that the inhibition was due to nitrosylation of
essential thiols in complex I [27^29]. We have re-
cently found that the S-nitrosothiols: S-nitroso-N-
acetyl-D,L-penicillamine (SNAP) and S-nitrosogluta-
thione (SNOG) can inhibit complex I in mitochon-
dria even in conditions when there is very little NO
release from the nitrosothiols (in the dark and pres-
ence of copper chelators), and this inhibition can be
reversed by light and reduced thiols [30]. This sug-
gests the possibility that complex I activity may be
regulated by reversible S-nitrosylation. Creatine ki-
nase [31,32] and the mitochondrial permeability tran-
sition pore [33] also appear to be sensitive to nitro-
sothiols.
It is possible that brain cells respond to NO in a
somewhat di¡erent manner than other cells. Com-
plex I in isolated brain mitochondria appears to be
relatively resistant to the direct actions of peroxyni-
trite [34]. However, this sensitivity may be critically
dependent on the concentration of mitochondria
used and the presence of substrates, as peroxynitrite
may be scavenged by a wide variety of chemicals that
may be present in media [25]. Induction of iNOS in
astrocytes or brief exposure of cultured neurons to
peroxynitrite did not result in any loss of complex I
activity [35]. In contrast, when neurons were exposed
to SNAP for 24 h, there was marked loss of complex
I activity, in conjunction with decreased activity of
complexes II, III and IV [36]. Under such conditions
there was a marked loss of neuronal glutathione
(GSH). When compared to neurons, astrocytes ap-
pear relatively resistant to peroxynitrite [34]. But
when astrocytes were depleted of GSH, they became
more sensitive to added peroxynitrite, accompanied
by marked inhibition of complex I following peroxy-
nitrite exposure [37]. These ¢ndings, together with
those in the previous paragraph, suggest that NO/
peroxynitrite/nitrosothiol-induced complex I inhibi-
tion only occurs after cellular GSH depletion.
Other irreversible or pathological e¡ects of NO
may be mediated by NO conversion to the strong
oxidants NO2 or N2O3 (see [1]), but we need to dis-
tinguish all such irreversible e¡ects of high levels of
NO from the acute, reversible inhibition of cyto-
chrome oxidase by low levels of NO, reviewed below.
Fig. 3. Main actions of nitric oxide (NO), peroxynitrite
(ONOO3) and nitrosothiols (RSNO) on mitochondria. NO spe-
ci¢cally and reversibly inhibits cytochrome oxidase (complex
IV); nitrosothiols inactivate complex I; whereas peroxynitrite
inhibits multiple respiratory complexes and aconitase, and acti-
vates the proton leak and permeability transition pore (ANT-
PTP), which may contribute to NO-induced cell death. Inhibi-
tions are indicated by dark arrows/bolts, while light ones indi-
cate activations.
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The major actions of NO and its derivatives on mi-
tochondria are summarised in Fig. 3.
3. Reversible NO inhibition of cytochrome oxidase
Cytochrome c oxidase (cytochrome aa3, complex
IV) is the terminal complex of the mitochondrial
respiratory chain, responsible for about 90% of oxy-
gen consumption in mammals, and is essential for
virtually all energy production in cells [38]. It is lo-
cated in the mitochondrial inner membrane, and cat-
alyses the oxidation of cytochrome c2 to cyto-
chrome c3 and the reduction of oxygen to water,
and this is coupled to the pumping of protons out
of the mitochondria. The oxidase contains two
haems (cyt a and cyt a3) and two copper centres
(CuA and CuB). Oxygen binds to the reduced form
of a binuclear centre consisting of cytochrome a3
(Fe2) and CuB (Cu1) within the complex, and
this constitutes the oxygen binding site and catalytic
centre of the oxidase [38].
NO binds to the oxygen binding site of cyto-
chrome oxidase [39^41]. This raises the possibility
that NO is an inhibitor of cytochrome oxidase in
competition with oxygen. That NO is indeed an in-
hibitor of cytochrome oxidase turnover was ¢rst re-
ported in 1994 [42^44], although an earlier report
strongly suggested this [45]. We [42] showed that
1 WM NO added to isolated cytochrome oxidase
caused an immediate inhibition of oxygen consump-
tion that was completely reversed when the NO was
broken down. Thus NO is a potent, rapid and re-
versible inhibitor of cytochrome oxidase. We [42]
also showed that NO reversibly inhibited the oxygen
consumption of isolated synaptosomes, which are
neuronal nerve terminals isolated from the brain,
and are packed with neuronal mitochondria. We
found [42] that the NO inhibition of oxygen con-
sumption was competitive with oxygen, half inhibi-
tion of synaptosomal oxygen consumption occurred
at 270 nM NO when the oxygen concentration was
about 145 WM O2 (roughly the arterial level of oxy-
gen), but half inhibition occurred at 60 nM NO when
the oxygen concentration was 30 WM (roughly the
mean tissue level of oxygen) (Fig. 4). We subse-
quently [46] reported that similar levels of NO revers-
ibly inhibited respiration in isolated heart mitochon-
dria due to the inhibition of cytochrome oxidase, but
oxygen consumption was markedly less sensitive to
NO in state 4 than in state 3, probably because cy-
tochrome oxidase has less control over (is less rate
limiting for) mitochondrial respiration rate in state 4.
Cassina and Radi [23] reported that somewhat higher
levels of NO were required to inhibit oxygen con-
sumption in heart mitochondria, but they did not
actually measure the levels of NO. Poderoso et al.
[47,48] found that 0.1 WM NO half-inhibited cyto-
chrome oxidase activity in submitochondrial par-
ticles, and 0.5 WM NO half-inhibited oxygen con-
sumption in heart mitochondria at unspeci¢ed
oxygen levels (probably high). Others [49^52] re-
ported that addition of about 1^4 WM NO to isolated
mitochondria caused inhibition of oxygen consump-
tion and ATP synthesis, which was greater at lower
oxygen levels and largely reversible. Cleeter et al. [43]
showed that an NO donor caused a reversible inhi-
bition of oxygen consumption in isolated skeletal
muscle mitochondria due to inhibition of cytochrome
oxidase. Lizasoain et al. [24] demonstrated that NO
donors reversibly inhibited the respiration of submi-
tochondrial particles at cytochrome oxidase with an
apparent half inhibition by 2 WM NO. Schweizer and
Richter [44] found that about 1 WM NO caused a
Fig. 4. Dependence on NO concentration of the oxygen con-
sumption of synaptosomes at two di¡erent oxygen concentra-
tions. Synaptosomes (nerve terminals isolated from the brain,
containing many mitochondria) were incubated in a sealed,
stirred vessel with NO at two di¡erent oxygen levels, with an
oxygen and NO electrode. Adapted from Brown and Cooper
[42].
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reversible inhibition of oxygen consumption in iso-
lated liver and brain mitochondria, and this resulted
in a reversible depolarisation of the mitochondrial
membrane potential and e¥ux of mitochondrial cal-
cium, which was greater at lower oxygen concentra-
tions.
NO also potently inhibits the cytochrome oxidase
activity of Paracoccus denitrifans [45] and Escherichia
coli [53], and this might contribute to bacterial tox-
icity of NO. Cytochrome oxidase within higher plant
mitochondria is also inhibited by NO [54].
In isolated cytochrome oxidase (from beef heart)
Torres et al. [55] and Giu¡re et al. [56] found NO
binding to the oxygen binding site was competitive
with oxygen, and due to NO binding to a partially
reduced form of the cyt a3-CuB binuclear centre.
Thus, in the presence of oxygen during turnover of
cytochrome oxidase, addition of NO resulted in an
optical spectrum identical to that of the oxidase^NO
complex in the absence of oxygen. The levels of NO
required for inhibition were somewhat higher than
those reported by us [42], but again the actual levels
of NO present were not measured. Light can disso-
ciate NO from the oxidase [40], and we have recently
found that light can reverse the NO inhibition of
mitochondrial respiration [30]. NO is known to
bind rapidly to the Fe2 of cyt a3 (k = 0.4^1.0U108
M31 s31) [41], and NO dissociates from the oxidase
slowly (although relatively rapidly compared to other
haemproteins, k = 0.1^0.01 M31 s31) [56], indicating
a very high a⁄nity of the reduced enzyme for NO
(Kd about 1 nM). But oxygen also binds rapidly to
the Fe2 of cyt a3 (k = 108 M31 s31) [38], and at high
ratios of oxygen to NO (normally s 1000:1) it ap-
pears anomalous that NO can inhibit cytochrome
oxidase so rapidly (less than 1 s) by binding to cyt
a3 alone. Thus Torres et al. [55] proposed that during
turnover, NO preferentially binds to the reduced
form of CuB (Cu1), which then somehow gives
NO a kinetic advantage over oxygen in binding to
the Fe2 of cyt a3. They subsequently suggested and
provided evidence that NO binds to Cu2B , forming
Cu1^NO, the nitrosonium (NO) may then hy-
drate to give nitrite, which may inhibit the oxidase
[57]. Nitrite is a poor inhibitor of the oxidase when
added externally (requiring high millimolar concen-
trations), but if formed within the binuclear centre it
can be an e¡ective inhibitor, because di¡usion out
of (or into) the binuclear centre pocket is slow.
The binding of NO to Cu1 or Cu2 might be the
major pathway for rapid inhibition of the oxidase.
However, Giu¡re et al. [56] believe that the rapid
onset of inhibition may be explained in terms of
rapid binding of NO to the Fe2 of the partially
reduced binuclear centre. Oxygen only binds to the
fully reduced binuclear centre (Fe2^Cu1), not to
the partially reduced forms (Fe2^Cu2 or Fe3^
Cu1), thus if NO could bind to either of the latter,
it would gain a kinetic advantage over oxygen in
binding and inhibiting the binuclear centre. What-
ever the mechanism of rapid inhibition by NO, it is
clear that only the reaction of NO with the (par-
tially or totally) reduced binuclear centre can ac-
count for the competition between oxygen and NO,
which is characteristic of this form of respiratory
inhibition by NO. Reactions of NO with cytochrome
oxidase have previously been studied by Brudvig
et al. [39].
Because NO competes with oxygen at cytochrome
oxidase, NO acts to increase the apparent Km of
respiration for oxygen [42], and this led me [58] to
suggest that NO may be a physiological regulator of
the oxygen sensitivity of respiration in tissues. Koi-
visto et al. [59] reinvestigated the competition be-
tween NO and oxygen in isolated mitochondria
from brown adipose tissue, and found that half inhi-
bition of respiration occurred at 364 nM NO with
180 WM O2, 69 nM NO with 72 WM O2, and 11 nM
NO with 32 WM O2. Thus the IC50 of NO increased
roughly in proportion to the square of the oxygen
tension, and in the presence of NO the dependence of
respiration on oxygen tension had a Hill coe⁄cient
of about 2. Koivisto et al. [59] suggested that this
might be caused by two molecules of NO competing
with one molecule of O2 ; however, Stubauer et al.
[60] showed that only one molecule of NO bound to
cytochrome oxidase (at least in the reduced form). It
is not clear why Koivisto et al. [59] found a di¡erent
oxygen dependence of the NO inhibition of respira-
tion than that found by Brown and Cooper [42] (re-
produced in Fig. 4). But it may well be a conse-
quence of the di⁄culty of measuring inhibited
respiration rates at low oxygen levels in an ordinary
Clarke oxygen electrode. Since the average level of
oxygen in mammalian tissues is about 30 WM O2, the
results of Koivisto et al. [59] emphasise that even low
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physiological levels of NO (1^200 nM NO) can cause
substantial inhibition of respiration, and potentially
make tissue respiration very sensitive to the oxygen
tension.
NO can be produced by three di¡erent isoforms of
NO synthase (eNOS, nNOS and iNOS), located in
the cytosol or cell membranes, but NO synthase ac-
tivity or proteins binding to NOS-speci¢c antibodies
have been found in isolated mitochondria, indicating
either that one of the three known isoforms can bind
to or be transported into mitochondria, or that there
is a new mitochondrial isoform (mtNOS) [8,61^63].
Giulivi et al. [64] measured NO production by Per-
coll-puri¢ed liver mitochondria using either oxymyo-
globin or an EPR spin trap to measure NO. They
found an arginine-dependent and NMMA-inhibit-
able NO production of 1.4 nmol/min/mg protein in
intact mitochondria, and this activity was greater in
submitochondrial particles, suggesting that the NOS
was located on the inner mitochondrial membrane.
Tatoyan and Giulivi [9] puri¢ed the protein respon-
sible for this activity to homogeneity from the same
liver mitochondria, and showed that it was similar or
identical to iNOS based on kinetic parameters, mo-
lecular weight, requirement for cofactors, and cross-
reactivity to monoclonal antibodies to iNOS from
macrophages. Whether this mitochondrial NOS
(mtNOS) is in fact a distinct isoform of NOS is yet
to be determined. Giulivi [65] further investigated the
functional implications of this NO production for
mitochondrial respiration in isolated liver mitochon-
dria. It was found that the endogenously produced
NO was dependent on the presence of L-arginine,
was inhibited by N-methyl-L-arginine, and was de-
pendent on the respiratory state of the mitochondria
in such a way as to suggest that the NO production
was supported by mitochondrial NADPH. The en-
dogenous NO signi¢cantly inhibited state 4 and state
3 respiration and ATP production. Ghafourifar and
Richter [8,66] found that mitochondrial NO produc-
tion was stimulated by calcium, and the NO so pro-
duced could decrease mitochondrial respiration,
membrane potential and pH gradient, and regulate
mitochondrial pH and calcium bu¡ering. They fur-
ther found that calcium stimulation of mtNOS may
contribute to calcium activation of cytochrome c re-
lease and subsequent apoptosis [67]. Thus, the high
activity of mtNOS, location on the inner mitochon-
drial membrane, and demonstration that it can reg-
ulate mitochondrial respiration suggests that it may
in fact function to regulate mitochondrial respiration
physiologically. However, doubts still remain as to
the nature and signi¢cance of mtNOS. Recently it
was suggested that mitochondria may produce NO
by another mechanism, due to reduction of nitrite to
NO by ubisemiquinone in the cytochrome bc1 com-
plex [68].
NO may also be consumed by mitochondria due
to (a) reaction with mitochondrial superoxide to pro-
duce peroxynitrite, (b) reaction with ubiquinol to
produce ubiquinone and NO3, which may then fur-
ther react to give N2O or peroxynitrite, and possibly
(c) reaction at cytochrome oxidase to produce N2O
and nitrite [46,69,70]. The production of peroxyni-
trite by mitochondria might contribute to irreversible
inhibition of respiration.
The cell membrane is permeable to NO, and thus
NO (or NO donors) added to cells causes rapid and
oxygen-dependent inhibition of respiration at cyto-
chrome oxidase in neuronal nerve terminals [42,71],
hepatocytes [72], astrocytes [73], pancreatic L-cells
[74], kidney tubules [75], neurons [76] and ascites
tumour cells [51]. This respiratory inhibition was
largely reversed when the NO was removed, although
there was also an irreversible component to the inhi-
bition in some cases (e.g. [36]). The reversible inhibi-
tion of respiration by NO resulted in a reversible and
oxygen-dependent decrease in mitochondrial mem-
brane potential and increase in cytosolic calcium
(probably due to e¥ux of mitochondrial calcium)
in hepatocytes [72], and pancreatic L-cells [74], and
a decrease in mitochondrial membrane potential and
cellular ATP in ascites tumour cells [51] and neurons
[76]. NO-induced respiratory inhibition was also ac-
companied by insulin release by L-cells and intact
pancreatic islets [74] and glutamate release by nerve
terminals [71].
However, the above ¢ndings that addition of NO
to in vitro system causes inhibition of respiration at
cytochrome oxidase is not su⁄cient to show that NO
is a physiological regulator or pathological inhibitor
of mitochondrial respiration. For this we need to
know whether NO produced endogenously by NO
synthase in cells causes reversible inhibition of cellu-
lar respiration. Such research is reviewed in the next
section.
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4. Reversible inhibition of mitochondrial respiration
by NO endogenously produced by cells, tissues, and
in vivo
Investigation of whether NO can regulate respira-
tion in cells, tissues and in vivo is important but
complicated by several factors. (1) NO can react
with cellular constituents to produce peroxynitrite,
nitrosothiols and other derivatives of NO, which
may a¡ect respiration but generally cause an irrevers-
ible inhibition. (2) NO may a¡ect ATP consumption
(or respiratory substrate supply), which will indi-
rectly change cellular oxygen consumption, in partic-
ular NO can a¡ect muscle contraction by cGMP-de-
pendent mechanisms [77]. (3) NO is a potent
vasodilator and thus increases oxygen supply. (4)
NO reacts rapidly with haemoglobin and myoglobin.
Thus these experiments can be di⁄cult to interpret
mechanistically.
A variety of cells, including macrophages, astro-
cytes, hepatocytes, and myocytes, can be induced to
express the inducible form of NO synthase (iNOS) by
cytokines, endotoxins, and/or oxidative stress, lead-
ing to the production of a sustained high level of NO
[17,73]. We used primary cultures of astrocytes, iso-
lated from brain, activated to express iNOS by inter-
feron-Q and endotoxin and found to produce up to
1 WM NO, and this endogenous NO caused potent
inhibition of cellular respiration at cytochrome oxi-
dase, which was rapidly reversed by either removing
the NO with oxyhaemoglobin or by inhibiting NO
synthase [73]. We also found that a macrophage cell
line (J774) activated to express iNOS caused rapid
and strong inhibition of the cellular respiration of
co-incubated cells (L929 ¢broblasts or non-activated
macrophages) via the reversible NO inhibition of cy-
tochrome oxidase [78]. Furthermore we have found
that primary cultures of endothelial cells, expressing
the constitutive, endothelial form of NO synthase
(eNOS), when stimulated with bradykinin or ATP,
release a brief pulse of NO, which causes a brief,
transient inhibition of cellular respiration due to
the inhibition of cytochrome oxidase [79]. Also the
background, unstimulated release of NO was su⁄-
cient to partially inhibit endothelial cell respiration,
and strongly increases the apparent Km of respiration
for oxygen, so that inhibition of NOS caused a stim-
ulation of respiration and decrease in Km for oxygen.
Miles et al. [80] found that inhibition of NO syn-
thase in lung alveolar type II cells caused an increase
in cellular oxygen consumption and ATP concentra-
tions, while an NO donor caused the opposite e¡ect,
suggesting that constitutive NO production was in-
hibiting respiration. Similarly Sarti et al. [81] re-
ported that addition of NOS inhibitors to neuroblas-
toma cells rapidly increased the mitochondrial
membrane potential within the cells, while NO do-
nors had the opposite e¡ect, again suggesting a con-
stitutive inhibition of cytochrome oxidase by NO
within cells. Shen et al. [82] found that addition of
the endothelial agonists bradykinin or carbachol to
in vitro slices of skeletal muscle caused NO-depen-
dent inhibition of oxygen consumption. A cell-per-
meable form of cGMP (8-bromo-cGMP) also caused
an inhibition of oxygen consumption by the muscle
slices, suggesting that part of the inhibition may have
been mediated by cGMP. However, in the presence
of a mitochondrial uncoupler (dinitrophenol) bromo-
cGMP did not inhibit respiration, while bradykinin
still inhibited respiration, suggesting that at least part
of the inhibition was due to a direct e¡ect of NO on
the respiratory chain. In heart muscle slices incu-
bated in vitro Xie et al. [83] found that bradykinin
and carbachol caused an NO-dependent inhibition of
tissue respiration that was not mimicked by cell-per-
meable cGMP and also occurred in the presence of a
mitochondrial uncoupler. A similar bradykinin-in-
duced inhibition of respiration was found in the iso-
lated left ventricle wall of mice, but was absent in the
wall from eNOS knockout mice [84]. These results
suggest that endothelial agonists cause activation of
eNOS and the NO produced di¡uses from the endo-
thelium to myocytes, where the NO directly inhibits
the mitochondrial respiratory chain or substrate sup-
ply. However, the reversibility and oxygen depen-
dence of this inhibition were not measured, so we
can not be sure that it was due to NO inhibition of
cytochrome oxidase. Poderoso et al. [48] used iso-
lated, perfused rat heart and showed that bradykinin
caused a 30^40% decrease in oxygen consumption,
associated with an increase in NO concentration in
the e¥uent, vasodilation of the coronary vasculature,
but no signi¢cant decrease in left ventricular pres-
sure. These e¡ects were blocked by inhibiting NO
synthase with N-monomethyl-L-arginine. These re-
sults suggest that bradykinin-evoked NO release
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from the endothelium can inhibit myocyte oxygen
consumption, but again the reversibility, oxygen
and cGMP dependence of the inhibition was not
measured, so the mechanism of the inhibition is un-
clear.
In vivo in conscious dogs Shen et al. [85] found
that an inhibitor of NO synthase (NMA, N-nitro-L-
arginine) caused a rapid and sustained 25% increase
in whole body oxygen consumption (estimated from
cardiac output and oxygen extraction), even though
the oxygen available to tissues was decreased due to
the haemodynamic changes. Barbiturate (pentobarbi-
tal) anaesthetised dogs did not show the NMA-in-
duced stimulation of oxygen consumption. Shen et
al. [82] found that NMA also increased the oxygen
consumption in hind limb skeletal muscle of con-
scious dogs by 55%. And Laycock et al. [86] using
the same model found that NMA increased the oxy-
gen consumption of the kidneys by 58% in vivo,
though sodium reabsorption was decreased, suggest-
ing that kidney respiration was inhibited directly by
endogenous NO. They also found that bradykinin or
NO donors decreased the oxygen consumption renal
slices in vitro. King et al. [87] also found that NOS
inhibition caused a 40% increase in the oxygen con-
sumption of hind limb skeletal muscle of anaesthe-
tised dogs, despite a decrease in blood £ow. Ishibashi
et al. [88] found that NMA caused a 28% increase in
heart oxygen consumption of exercising dogs. Loke
et al. [89] found that administration of blood-free
haemoglobin conjugates (that e⁄ciently scavenge
NO) to conscious dogs doubled heart oxygen con-
sumption, while decreasing fatty acid oxidation and
increasing glucose and lactate oxidation.
All of the above results are consistent with the
interpretation that basal constitutive NO release by
capillary endothelium or by NOS within muscle cells
tonically inhibits tissue respiration. However, it can
not be ruled out that this inhibition is mediated via
cGMP and/or ATP consumption, as cGMP can
weakly inhibit oxygen consumption of muscle slices
[82], and can inhibit isolated myocyte contraction
[77] and oxygen consumption [90].
In contrast to the concept that cGMP can inhibit
muscle and heart oxygen consumption, it has been
reported that cGMP and NO donors can stimulate
the oxidation of glucose, pyruvate, palmitate and
leucine in isolated soleus muscle via cGMP-depen-
dent mechanism [91^93]. This stimulation was sug-
gested to be involved in the physiological stimulation
of glucose oxidation by muscle. However, in heart in
vivo endogenous NO appears to stimulate fatty acid
oxidation and inhibit carbohydrate oxidation, while
inhibiting oxygen consumption [89,94]. The mecha-
nism by which NO changes substrate utilisation is
unknown. Clearly more work needs to be done to
untangle the multiple e¡ects of NO/cGMP on respi-
ration within tissues and in vivo.
5. Discussion
Can the NO inhibition of cytochrome oxidase me-
diate a physiological regulation of respiration by
NO? The evidence from in vitro systems is clear
that NO could play such a role. However, in vivo
NO rapidly reacts with myoglobin and haemoglobin
so that the NO level may never reach a level in vivo
at which cytochrome oxidase is inhibited. On the
other hand this argument equally applies to the
NO activation of the soluble guanylate cyclase,
which certainly does occur in vivo. The levels of
NO present in vivo are unclear at present, partly
because the only measurements so far made in vivo
(10 nM^5 WM NO) are with a porphyrinic-based
NO-selective electrode (rather than the more com-
monly used Clarke-type polarographic electrode),
which apparently measures the NO within the mem-
brane bilayers where the NO concentration is higher
[95]. However, the use of NO synthase inhibitors in
vivo has shown that inhibiting the basal NO produc-
tion causes a marked stimulation of tissue and whole
body oxygen consumption, consistent with a basal
inhibition of tissue respiration by NO. On the other
hand we do not yet know that this stimulation is not
mediated by cGMP or some other mechanism, rather
than by cytochrome oxidase. Further in vivo experi-
ments are required to determine whether NO really is
a direct physiological regulator of oxidative phos-
phorylation.
I have previously pointed out that the NO inhibi-
tion of cytochrome oxidase increases the apparent
Km of mitochondrial respiration for oxygen into
the physiological range of oxygen concentrations,
thus potentially making respiration sensitive to oxy-
gen supply [58]. In a variety of tissues, organisms and
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conditions respiration can become very sensitive to
the oxygen level [96,97], and the competition between
NO and oxygen at cytochrome oxidase might play a
role in this sensitivity. However, there is no direct
evidence for this in vivo, and it should be noted
that the apparent Km of NO synthase for oxygen is
at least an order of magnitude higher than that of
cytochrome oxidase (in the absence of NO), so that
at moderately low oxygen levels NO synthase might
be unable to produce su⁄cient NO to inhibit cyto-
chrome oxidase. Note, however, that during ischae-
mia, tissue pH decreases and may promote the re-
duction of nitrite to NO in the absence of oxygen
[10], thus potentially causing potent inhibition of cy-
tochrome oxidase at low oxygen levels.
Fig. 5 summarises the potential role of NO in reg-
ulating mitochondrial respiration. Constitutive forms
of NOS present in endothelium (eNOS), neurons
(nNOS) and other cells such as myocytes (eNOS
and nNOS) may produce NO acutely and transiently
when stimulated by appropriate agonists, resulting in
a transient inhibition of respiration in these and sur-
rounding cells, which might function either to regu-
late thermogenesis, ATP-dependent functions or oxy-
gen sensitivity. If mtNOS exists it may play similar
roles. iNOS, when expressed in macrophages and
many other cells in in£ammatory conditions, produ-
ces sustained, high levels of NO, which is likely to
strongly inhibit respiration in these and surrounding
cells, potentially causing cytotoxicity in those cells
that are unable to survive on glycolytic ATP produc-
tion.
The physiological/teleological role of NO regula-
tion of mitochondrial respiration is unclear, and
the following is speculation. NO from iNOS and
from constitutive NOS (eNOS and nNOS) probably
have di¡erent roles, as iNOS produces higher levels
for a sustained period. The main role of iNOS ex-
pression during in£ammation appears to be to sup-
press proliferation and induce cytostasis of patho-
gens, host cells, and tumour cells. The NO-induced
inhibition of respiration within these cells may well
contribute to the cytostasis and cytotoxicity, and
there is some evidence for this role in vitro, but not
so far in vivo. In terms of constitutive NOS we need
to distinguish between several possible modes of reg-
ulation: (a) transcellular/paracrine regulation of one
cell by another, (b) intracellular/autocrine regulation
of a cell’s respiration by NO produced within that
cell, and (c) intramitochondrial regulation by NO
produced within the mitochondria. Transcellular res-
piration might act to regulate respiration in sur-
rounding cells due to NO production by: (a) endo-
thelium or (b) neurons. Endothelial NO might
regulate respiration in (a) vascular smooth muscle
in blood vessels, or (b) tissue cells regulated by capil-
lary endothelium. The latter might allow hormones
or other humoral factors to regulate tissue respira-
tion. In the peripheral nervous system NO synthase
is expressed in some parasympathetic neurons and
might enable activity in this system to regulate tissue
respiration.
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